Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109300524 | 10930052 | 4 | F | 201303 | 20160912 | 20150319 | 20160919 | EXP | US-JNJFOC-20150312840 | JANSSEN | 73.39 | YR | E | F | Y | 53.60000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109300524 | 10930052 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | 0 | 20 | MG | TABLET | |||||||
| 109300524 | 10930052 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | 202439 | 20 | MG | TABLET | |||||||
| 109300524 | 10930052 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLETS | QD | |||||||
| 109300524 | 10930052 | 4 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 109300524 | 10930052 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 109300524 | 10930052 | 6 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 109300524 | 10930052 | 7 | C | SOTALOL. | SOTALOL | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 109300524 | 10930052 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 109300524 | 10930052 | 9 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | D | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109300524 | 10930052 | 1 | Atrial fibrillation |
| 109300524 | 10930052 | 2 | Cerebrovascular accident prophylaxis |
| 109300524 | 10930052 | 3 | Product used for unknown indication |
| 109300524 | 10930052 | 4 | Atrial fibrillation |
| 109300524 | 10930052 | 5 | Product used for unknown indication |
| 109300524 | 10930052 | 6 | Product used for unknown indication |
| 109300524 | 10930052 | 7 | Product used for unknown indication |
| 109300524 | 10930052 | 8 | Product used for unknown indication |
| 109300524 | 10930052 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109300524 | 10930052 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109300524 | 10930052 | Coagulopathy | |
| 109300524 | 10930052 | Epistaxis | |
| 109300524 | 10930052 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109300524 | 10930052 | 1 | 20130306 | 20130310 | 0 | |
| 109300524 | 10930052 | 2 | 20130306 | 20130310 | 0 | |
| 109300524 | 10930052 | 4 | 20130101 | 20130305 | 0 |